Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Step 3: Consult your doctor
The company submitted a regulatory approval application for the therapy to South Koreas Ministry of Food and Drug Safety on Dec
The GLP-1 Agonist Market is going through a big change because of fast technological progress, changing consumer needs, and the rise of next-generation applications in core industries
The 175-patient study in cardiovascular risk and obesity met its primary safety endpoint, with treatment-emergent adverse events similar between VTX3232 (46%) and placebo (49%) cohorts
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
